Rivastigmine tartrate Good Manufacturer supply High Quality 129101-54-8
- Molecular Formula:C18H28N2O8
- Molecular Weight:400.43
- Appearance/Colour:white to off-white powder
- Vapor Pressure:0.000416mmHg at 25°C
- Melting Point:123-125 ºC
- Boiling Point:316.2 ºC at 760 mmHg
- Flash Point:145 ºC
- PSA：147.84000
- LogP:0.63710
Rivastigmine tartrate (129101-54-8) Usage
Rivastigmine tartrate is a tartrate salt obtained by the reaction of rivastigmine with one equivalent of (R,R)-tartaric acid. It is a reversible cholinesterase inhibitor, characterized by its white to off-white powder appearance. Rivastigmine tartrate is a brain selective acetylcholinesterase inhibitor and is classified as a nootropic, which means it enhances cognitive function and memory.
How to get the best price on Rivastigmine tartrate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Rivastigmine tartrate . You can buy high quality, low price Rivastigmine tartrate 129101-54-8 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
